Dr Reddy’s Labs Slides to 52-Week Low

Dr Reddy’s Laboratories, a big pharma company, recently reported its first-quarter results, which were not as good as expected.

This made the company's share price drop to its lowest point in the past year.

The company's earnings were lower than what analysts predicted, mainly because of fewer sales of a medicine called Lenalidomide, price cuts in the US and Europe, problems with another medicine called Semaglutide, and higher costs due to a crisis in the Middle East.

Some experts think the company will do better in the future because of new medicines and growth in India.

However, others think the company will struggle in the short term due to higher costs and slower growth in some areas.

The company's share price has been going down over the past few months and years.